COT-7 Online supports for opening of the tumor treating field

Background: EF-14 trial showed the efficacy of tumor treating fields (TTF), and TTF was approved as a standard therapy for glioblastoma in Japan. In TTF opening, Device Support Specialist (DSS) explains how to use it for the patient and the family. Because there is no DSS in Yamaguchi prefecture, DS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadahiro, Hirokazu, Sugimoto, Kazutaka, Nomura, Sadahiro, Ishihara, Hideyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Supplement Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648226/
http://dx.doi.org/10.1093/noajnl/vdab159.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8648226/
http://dx.doi.org/10.1093/noajnl/vdab159.113

Ejemplares similares